美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SpyGlass Pharma Inc

26.40

+10.4065.00%

盘后：25.63-0.7700-2.92%18:40 EST

成交量：119.48万

成交额：3,112.29万

市值：8.42亿

市盈率：- -

高：32.44

开：24.00

低：20.16

收：16.00

52周最高：32.44

52周最低：20.16

股本：3,191.12万

流通股本：940.00万

量比：- -

换手率：12.71%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

异动解读 | SpyGlass Pharma纳斯达克IPO首日开盘价翻倍，盘中大涨50%

BUZZ-SpyGlass 在纳斯达克首次公开募股 1.5 亿美元后有望高开

美股异动 | SpyGlass Pharma(SGP.US)登陆美股市场开盘暴涨超43%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SGP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","market":"US","secType":"STK","nameCN":"SpyGlass Pharma Inc","latestPrice":26.4,"timestamp":1770411600000,"preClose":16,"halted":0,"volume":1194807,"hourTrading":{"tag":"盘后","latestPrice":25.63,"preClose":26.4,"latestTime":"18:40 EST","volume":12896,"amount":346085.82528,"timestamp":1770421227513,"change":-0.77,"changeRate":-0.029167,"amplitude":0.082197},"delay":0,"changeRate":0.6499999999999999,"floatShares":9400000,"shares":31911200,"eps":0,"marketStatus":"盘后交易","change":10.4,"latestTime":"02-06 18:41:57 EST","open":24,"high":32.44,"low":20.16,"amount":31122895.490096997,"amplitude":0.7675,"askPrice":26.5,"askSize":47,"bidPrice":25.5,"bidSize":20,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770426000000},"marketStatusCode":4,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":16,"postHourTrading":{"tag":"盘后","latestPrice":25.63,"preClose":26.4,"latestTime":"18:40 EST","volume":12896,"amount":346085.82528,"timestamp":1770421227513,"change":-0.77,"changeRate":-0.029167,"amplitude":0.082197},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","floatShares":9400000,"roa":"--","roe":"--","lyrEps":0,"shares":31911200,"dividePrice":0,"high":32.44,"amplitude":0.7675,"preClose":16,"low":20.16,"week52Low":20.16,"pbRate":"--","week52High":32.44,"institutionHeld":0,"latestPrice":26.4,"committee":-0.402985,"eps":0,"divideRate":0,"volume":1194807,"delay":0,"ttmEps":0,"open":24,"prevYearClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173758808","title":"异动解读 | SpyGlass Pharma纳斯达克IPO首日开盘价翻倍，盘中大涨50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173758808","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173758808?lang=zh_cn&edition=fundamental","pubTime":"2026-02-07 01:29","pubTimestamp":1770398971,"startTime":"0","endTime":"0","summary":"生物制药公司SpyGlass Pharma, Inc.今日盘中股价大幅上涨，涨幅达到50.00%，引起了市场的广泛关注。消息面上，SpyGlass Pharma今日在纳斯达克成功完成首次公开募股，开盘价达到每股32美元，远高于其16美元的发行价。此次IPO以每股15至17美元的价格区间出售了约940万股股票，共融资1.5亿美元。SpyGlass Pharma成立于2019年，专注于为慢性眼病开发长效疗法的药物输送系统。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SGP"],"gpt_icon":0},{"id":"2609898590","title":"BUZZ-SpyGlass 在纳斯达克首次公开募股 1.5 亿美元后有望高开","url":"https://stock-news.laohu8.com/highlight/detail?id=2609898590","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609898590?lang=zh_cn&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393659,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4T3Z21PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0162691827.USD","LU0098860793.USD","LU2417539215.USD","BK4588","LU0072461881.USD","BK4566","LU1506573853.SGD","LU1267930227.SGD","BK4534","BK4559","LU0648001328.SGD","LU0314106906.USD","LU0052756011.USD","LU1244550494.USD","LU1791807156.HKD","LU1366192091.USD","LU0130102774.USD","LU1162221912.USD","LU1668664300.SGD","LU0980610538.SGD","LU1244550577.SGD","LU0130517989.USD","LU2462157665.USD","SGP","BK4127","LU0128525689.USD","SF","LU2125154778.USD","BK4207","IE00BSNM7G36.USD","LU0170899867.USD","LU1201861249.SGD","LU0310800965.SGD","LU2456880835.USD","LU0477156953.USD","LU2125154935.USD","LU0320765646.SGD","BK4585","LU2360032135.SGD","MNSH","BK4504","LU2236285917.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2609839513","title":"美股异动 | SpyGlass Pharma(SGP.US)登陆美股市场 开盘暴涨超43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609839513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609839513?lang=zh_cn&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，SpyGlass Pharma(SGP.US)登陆美股市场，开盘股价暴涨超43%，报23美元，IPO价格为16美元。SpyGlass Pharma 是一家临床后期生物技术公司，专注于开发 用于慢性眼部疾病的持续药物输送系统，旨在通过更长效、可持续的治疗方案改善患者的视力和生活质量。其核心研发产品包括一种将药物输送垫与人工晶状体结合的系统，用于治疗像 开角型青光眼或眼压高 等慢性眼病。这类治疗目标是提高疗效和患者依从性，与传统每日滴眼药水相比有潜在优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4535","BK4550","MNQmain","TWM","BK4585","RWM","BK4581","SGP","BK4534","IWO","SRTY","BK4588","UWM","TZA","TNA","IWN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}